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Background: Pharmaceuticals used in human medical care are not completely eliminated in the human body and
can enter the municipal sewage sludge system and leachate water from landfill both as the parent compound and
as their biologically active metabolites. The selective serotonin reuptake inhibitors (SSRIs) have a large potential for
unwanted effects on nontarget organisms in the environment. Leachates from active or old closed landfills are
often treated with continuous stirring and simple aeration in a pond/lagoon before infiltration into the
environment. The aim of this work was to simulate the reduction of five SSRIs (citalopram, fluoxetine, paroxetine,
sertraline and fluvoxamine) and three of their metabolites (desmethylcitalopram, didesmethylcitalopram and
norfluoxetine) during aerobic treatment of leachate from landfills. This landfill leachate-simulation experiment was
performed to see what happens with the pharmaceuticals during aerated treatment and continuous stirring of
landfill leachate for 120 h. It is important to establish whether different pollutants such as pharmaceuticals can be
removed (oxidized or otherwise degraded) or not before infiltration into the environment.
Results: All the SSRIs had a significant concentration reduction during the aeration treatment process. Total SSRI
concentrations were reduced significantly during aerobic treatment, and the individual SSRIs were reduced by 89%
to 100% after 120 h. Among the high-concentration samples, fluoxetine (10 mg L−1) was the least degraded with
93% concentration reduction. Among the low-concentration samples, paroxetine was the least degraded with 89%
concentration reduction. Fluvoxamine and citalopram were most effectively eliminated and were completely removed
from both the high- and low-concentration samples. The samples were also investigated for the metabolites
desmethylcitalopram, didesmethylcitalopram and norfluoxetine but only norfluoxetine in the high-concentration
fluoxetine sample was detected.
Conclusions: Our results suggest that aeration is an effective method for eliminating pharmaceuticals such as
SSRIs from landfill leachate water. Comparing the results of all SSRIs with different treatment methods,
paroxetine and fluvoxamine seem to be the easiest compounds to eliminate independent of method, while
fluoxetine and sertraline seem to be the most stable.
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For several years, the occurrence of pharmaceuticals and
personal care products (PPCPs) in the aquatic environ-
ment has been recognized as one of the emerging issues
in environmental risk assessment [1-4]. Pharmaceuticals
used in human medical care are not completely elimi-
nated in the human body and can enter the municipal
sewage sludge system both as the parent compound and* Correspondence: ove.bergersen@bioforsk.no
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in any medium, provided the original work is pas their biologically active metabolites. These compounds
have a large potential for unwanted effects on nontarget
organisms in the environment. Several investigators have
examined the removal of pharmaceutical compounds dur-
ing the passage through municipal sewage treatment
systems [5-8]. Effluent concentrations and elimination
rates for different compounds vary significantly. Vari-
ous pharmaceutical compounds have been detected in
concentrations up to μg L−1 in sewage effluents, down-
stream of sewage treatment plants and in surface and
groundwater [2,9,10]. In addition to sewage treatment
plants, landfill sites where unused drugs and differentis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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these compounds into the environment. There are sev-
eral old landfill sites that were established when the
disposal of such compounds through garbage was tol-
erated, and drugs have been detected in leachates from
such municipal landfills [11]. Leachates from landfill
sites are also known to penetrate down to the ground-
water causing pollution [12].
Six selective serotonin reuptake inhibitors (SSRIs) are
on the Norwegian market today, fluoxetine, fluvoxamine,
paroxetine, sertraline, citalopram and escitalopram (the
pure S-enantiomer of citalopram). SSRIs are typically
used as antidepressants and are used to treat conditions
such as depression, anxiety disorders and some personal-
ity disorders. The total consumption of SSRIs has slowly
increased in Norway the last years, although when ad-
justed to population growth, the number of SSRI users
has been relatively stable at just below 4% of the popula-
tion. Citalopram/escitalopram is most widely distributed
and constitutes approximately 591 kg of the total amount,
while sertraline with its higher defined daily dosage is sold
in the largest amounts contributing with approximately
621 kg [13]. SSRIs have been found in wastewater in
Norway [8,14], and it is reasonable to believe that not all
pharmaceuticals are used or delivered back to the pharma-
cies but might end up on landfill sites through private gar-
bage disposal. Contaminants from landfill sites might
reach the environment through leachate water run-off,
and water soluble chemicals can reach the aquatic ecosys-
tems or the groundwater. SSRIs have been shown to have
a number of unwanted effects on aquatic organisms, such
as the behavioural effect fluoxetine has on fish [15] and
the induction of spawning and parturition in bivalves
[16,17]. Fluoxetine is probably the most studied SSRI
when it comes to effects on nontarget organisms, but ef-
fects from the other SSRIs have been found as well.
Depletion of SSRIs in sewage sludge has previously been
found during an aerobic composting process [18]. Vasskog
[18] showed that the depletion rate was highest for fluox-
etine (1.23 mg (kg ash/day)−1) and paroxetine (1.31 mg
(kg ash/day)−1) and lowest for citalopram (0.88 mg (kg
ash/day)−1). In addition, three out of four known SSRI me-
tabolites were detected in all compost samples, and two of
them showed a significant increase in concentrations dur-
ing the composting period.
PPCPs have also been investigated under anaerobic di-
gestion of sewage sludge [19-22], but SSRIs were not part
of these investigations. Carballa et al. [19] observed high
removal efficiencies for antibiotics, natural estrogens,
musk and naproxen, while for example carbamazepine
showed no elimination under anaerobic treatment of sew-
age sludge. Vieno et al. [20] also observed no elimination
of carbamazepine in their anaerobic treatment of raw
sewage, while fluoroquinolones were eliminated by >80%.Beta-blockers were found to be eliminated less than 65%.
Degradation was found for acetylsalicylic acid, while a
mixture of degradation and abiotic removal mechanisms
on other pharmaceuticals was observed during an anaer-
obic degradability study by Musson et al. [21]. The fate of
hormones and pharmaceuticals during combined anaer-
obic treatment and nitrogen removal in black water has
been investigated by de Graaff et al. [23]. They found that
only a few compounds were partly removed, and anaer-
obic treatment was effective only to remove the majority
of paracetamol. Falås et al. [24] have demonstrated that
there are large variations in removal of different pharma-
ceuticals within the same pharmaceutical class as well in
activated sludge. In this experiment, the nonsteroidal anti-
inflammatory drugs (NSAIDs) ibuprofen and naproxen
showed the highest removal rates, while diclofenac, mefe-
namic acid and clofibric acid showed little or no removal.
Bergersen et al. [25] have shown that anaerobic treatment
of sewage sludge gives a reduction in SSRI concentrations
from 32% (fluoxetine) to 98% (citalopram) in a 24-day ex-
periment, again demonstrating large variations within the
same pharmaceutical class.
Eggen et al. [26] have described that PPCPs from old
landfill leachate with treatment based on aeration and
sedimentation may represent a significant source of con-
cern for new and emerging pollutants in groundwater.
To our best knowledge, no studies have been con-
ducted on SSRIs in treatment of aerated landfill leachate.
When pharmaceuticals enter the environment through
landfill leachate systems, they may either be found in the
water phase or bound to particles. Landfill leachate aer-
ation ponds could treat the water via aeration and par-
ticulate matter sedimentation.
Based on earlier results showing that the removal of
SSRIs from sewage sludge is different during aerobic and
anaerobic treatment, it was interesting to compare this
with what would happen in the aeration process that
landfill leachate goes through.
The aim of this work was to simulate the possible elim-
ination of five SSRIs (citalopram, fluoxetine, paroxetine,
sertraline and fluvoxamine) and three of their metabolites
(desmethylcitalopram, didesmethylcitalopram and nor-
fluoxetine) during aerobic treatment of leachate from
landfills. Today, landfill leachates are treated with aeration
in a pond/lagoon before infiltration into the environment.
This landfill leachate-simulation experiment was per-
formed to see what happens with the pharmaceuticals
during aerated treatment and continuous stirring of
landfill leachate for 120 h. This experiment mimics the com-
mon process used for treatment of landfill leachate ponds
and aims to predict the efficiency of pharmaceutical removal
in aerated leachate ponds. It is important to establish
whether different pollutants such as pharmaceuticals can be
removed or not before infiltration into the environment.
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Aerobic treatment and oxygen consumption
Due to the use of the pharmaceutical compounds as a
carbon source combined with the carbon source in the
leachate, we followed the changing concentrations of each
SSRI in flasks with continuous stirring. Simultaneously,
we followed the changing consumption of oxygen within
the flasks headspace through 120 h (Figure 1). In landfill
leachate, prescription and nonprescription pharmaceutical
concentrations generally range from 100 to 10,000 ng L−1
[27]. The concentrations used in this experiment areFigure 1 Total OC after 120 h in Voith Sapromat exposed to different
and fluoxetine 10 and 1 mg L−1; fluvoxamine and citalopram 5 and 0.5 mg
without SSRIs is included.somewhat higher than what is found before to enhance
the effects seen on the experimental outcomes but are
still regarded as environmentally relevant. Each type of
SSRI with different concentrations could also give dif-
ferent oxygen consumption when present in landfill
leachate, which again will be valuable information about
the aerobic treatment of the landfill leachate.
Table 1 presents the ThOD for each SSRI, the total
OC after 48 and 120 h and the measured OC minus the
control sample (oxygen consumption of leachate) with-
out SSRI. All the calculated ThODs show lower valuesconcentrations of SSRIs in landfill leachate. Sertraline, paroxetine
L−1. Measured background respiration as control from leachate








48 h Tot. OC
Measured





mg L−1 mg L−1 mgO2 L−1 mgO2 L−1 mgO2 L−1 mgO2 L−1 mgO2 L−1
Fluvoxamine 5 6 11.0 300 424 49 99
0.5 0.61 1.1 317 370 66 55
Citalopram 5 3.2 13.1 340 445 89 120
0.5 0.39 1.3 290 401 39 76
Sertraline 10 10 30.2 482 787 101 311
1 1.33 3.0 488 740 107 264
Fluoxetine 10 11 22.8 340 950 135 661
1 0.84 2.3 290 802 85 513
Paroxetine 10 14 22.4 278 395 73 106
1 1.31 2.2 393 803 188 514
Measured oxygen consumption (Tot. OC) and OC* (Equation 1) after 48 and 120 h with each separate SSRI is compared with theoretical oxygen demand (ThOD)
of SSRI tablets. The results of measured total OC are given as mean values (n = 2). *Equation 1.
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All flasks spiked with the different SSRI tablets show
dissimilar oxygen consumption, although considerably
higher than the ThOD for each SSRI. This increased
oxygen consumption in the flasks might be due to (i) co-
metabolism between each SSRIs plus tablets excipients
and low decomposable carbon sources in the leachate,
which was not accessible alone in the control flask; (ii)
microbial co-metabolism between SSRIs and the carbon
source from the excipients in the tablets alone. Each tab-
let mixture used contained approximately 20% SSRIs
and 80% excipients. Each SSRI tablet contains a large
number of additives, e.g. carbon sources such as cellu-
lose, starch and glycerol.
The high induced oxygen consumption observed in the
flasks with paroxetine or fluoxetine in leachate substrate isTable 2 SSRI concentrations and pH at the beginning and aft
Measured at start
SSRI SSRI STDEV Rel. STDEV pH
mg L−1 mg L−1 %
Fluvoxamine 6.0 1.104 18 8.7
0.6 0.123 20 8.6
Citalopram 3.2 0.102 3 9.1
0.4 0.026 7 9.0
Sertraline 10.0 1.227 12 8.6
1.3 0.171 13 8.5
Fluoxetine 11.0 0.873 8 9.2
0.8 0.156 18 9.0
Norfluoxetine n.d.
n.d. n.d
Paroxetine 14.0 0.163 1 9.8
1.3 0.143 11 9.6
n.d., not detected.most likely due to the excipients (Figure 1 and Table 1).
Both these SSRI tablets have a higher amount of excipi-
ents than the other three SSRIs. The increased amount of
excipient gave considerably higher oxygen consumption
compared to the control samples and the other flasks
spiked with fluvoxamine, citalopram or sertraline. Figure 1
and Table 1 also show that each SSRI gave an increased
oxygen consumption compared to background consump-
tion in the control flasks after a minimum of 50 h inde-
pendent of SSRI concentration. After 120 h fluvoxamine
shows less oxygen consumption in the flask with 0.5 mg
L−1, while the other SSRIs show increased oxygen con-
sumption (Table 1). The diluted leachate solution without
SSRIs had an initial pH of 7.1, and when spiking the sam-
ples with SSRIs, the pH increased in all samples due to
the basic nature of the SSRIs (Table 2). The pH at start iner 120 h of the experiment
Measured at end
SSRI STDEV Rel. STDEV pH Reduction
mg L−1 mg L−1 % %
0.006 0.004 68 8.4 100
0.002 0.002 87 8.3 100
0.005 0.001 16 8.5 100
0.002 0.001 11 8.6 100
0.355 0.046 13 7.9 96
0.038 0.017 45 7.7 97
0.805 0.063 8 8.1 93
0.003 0.001 14 8.0 100
0.006 0.001 11
n.d.
0.105 0.011 11 8.0 99
0.141 0.003 2 7.9 89









(% per 21 days)
Reduction rate
(% per 24 days)
Reduction rate
(% per 5 days)
Fluvoxamine 88 53 100
Citalopram 26a 85 100
Sertraline 46a 38 96
Fluoxetine 35a 32 93a
Paroxetine 46 98 90
aMetabolites detected.
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tion) and 9.8 (paroxetine, high concentration). During the
120-h experiment, the pH was found to decrease in all
samples, and the exact values can be seen in Table 2. This
decrease in pH together with high oxygen consumption
could support an explanation that the SSRIs spiked in the
leachate have gone through an oxidation or are otherwise
reduced in concentration.
Earlier SSRIs have been investigated under aerobic and
anaerobic treatment processes of sewage waste to see if
the SSRIs deplete or accumulate. Vasskog et al. [18]
showed that all the SSRIs had a significant decrease in
concentration during aerobic treatment in a composting
process. Bergersen et al. [25] showed that paroxetine
and citalopram were almost completely reduced during
anaerobic treatment of sewage sludge while the lower re-
duction of fluoxetine, fluvoxamine and sertraline indi-
cate that these three compounds have a higher potential
for accumulation than citalopram and paroxetine under
anaerobic conditions. A review describing removal or
sorption of pharmaceuticals and other personal care
products in water treatment such as natural wetland sys-
tems concludes that these systems have a high potential
for removal of such chemicals [28]. One SSRI (fluoxet-
ine) has been found to be removed from wetland sys-
tems by sorption into duckweed [29]. To our best
knowledge, no studies have been conducted on SSRI de-
pletion in landfill leachate ponds treated with aeration.
Analysis and reduction of selective serotonin reuptake
inhibitors
The five selective serotonin reuptake inhibitors citalo-
pram, sertraline, paroxetine, fluvoxamine and fluoxetine
were analysed at the beginning and at the end of a 120-h
experiment in a Voith Sapromat respirometer to investi-
gate their concentration reduction during the process.
The concentrations were calculated as mg L−1 and com-
pared with the total theoretical amount of each SSRI if
no reduction had occurred in the samples. Table 1 shows
the theoretical concentration, measured concentration
and recovery of each SSRI before treatment. After treat-
ment for 120 h, all the SSRIs were measured at lower
concentrations at the end of the experiment. The results
shown in Table 2 give a detailed view of the concentration
of each SSRI and the depletion throughout the experi-
ment. All compounds showed a reduction in concentra-
tion of 89% to 100%, independent of high- or low-start
concentration. The recovery was measured at the begin-
ning of the experiment and was generally high (between
64% and 140%). The high recoveries of the SSRIs also
imply that there is low or no binding to particles and
humic acids in this experimental setup. There was no pos-
sibility to measure the recovery at the end of the experi-
ment, but it is expected to be equal to that at thebeginning. The highest recoveries (above 100%) might be
explained partly by the standard deviation but maybe
more likely by the fact that the added SSRI is taken from
crushed tablets. The weighed amount of the tablet might
not have been homogenous and the sample withdrawn
not representative. However, the main outcome of the ex-
periment would be the same, showing the concentration
reduction of the SSRIs during the experiment. There are
small differences between the recovery of the high and
low concentrations at the beginning of the experiment,
which also indicate that the recovery should be more or
less equal at even lower concentrations. Therefore, it is
most likely that the low concentrations found at the end
of the 120-h treatment were due to depletion of the com-
pounds and not low recovery.
Likewise, their metabolites desmethylcitalopram, dides-
methylcitalopram and norfluoxetine were analysed from
the treated samples to determine whether they were
formed during the experiment. Only one metabolite was
found in the samples, and norfluoxetine was detected in a
very low concentration (0.006 mg L−1) in the sample with
an initially high fluoxetine concentration (Table 2).
The experiment is set up to simulate the conditions in
a landfill leachate pond, and it is reasonable to believe
that the pharmaceuticals will have a similar degradation
profile in a full-size treatment system treated with aer-
ation for days or weeks.
The results in this experiment differ from earlier ex-
periments, where the same SSRIs were measured during
an aerobic composting and anaerobic sewage sludge
treatment [8,25]. By comparing the results from the aer-
obic and anaerobic experiment with this experiment,
both similarities and differences are found.
Table 3 illustrates a comparison of three different
treatment processes that show reduction efficiency and
reduction rate for all five SSRIs. First: All SSRIs show
considerable higher reduction rate in an aqueous aerated
media (Table 3). Second: In the aerobic composting
process [18], fluvoxamine and paroxetine had the high-
est reduction rates, while in the anaerobic experiment
Table 4 Chemical analysis of leachate water after dilution
used in the Voith Sapromat respirometer experiment
Parameter Units Raw material Diluted
leachate
TOC mg L−1 773 178
Tot-N mg L−1 322 74
Tot-S mg L−1 21 4.8
SO4 mg L−1 0.3 0.1
Fe mg L−1 16 3.7
Formic acid mg L−1 31 7.2
Acetic acid mg L−1 5.6 1.3
Propionic acid mg L−1 1.1 0.25
Butanoic acid mg L−1 1.5 0.3
Pentanoic acid mg L−1 3.2 0.7
Hexanoic acid mg L−1 2.4 0.6
Heptanoic acid mg L−1 1.3 0.3
DL- lactat mg L−1 5.5 1.3
BOD 7 mg L−1 430
Redox potential mV −148
pH 7.1 6.9
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oxetine had a very low reduction rate. The metabolite
norfluoxetine was detected in both aerobic experiments
while it was absent after anaerobic treatment. Third:
Citalopram was the most stable SSRI in the aerobic
composting experiment, while in the anaerobic sewage
sludge and in this aerated treatment experiment, it was
quickly reduced in concentration. Based on this experi-
ment, we can only assume that the differences in stabil-
ity in these three experiments might be due to the
different bacteria present in aerobic and anaerobic sys-
tems, but it could also originate from different chemical
reactions in the three systems since we cannot deter-
mine whether the concentration reduction is due to
chemical or biological degradation.
We are limited in the extent to which it is possible to
compare three functionally different systems, especially
when we consider the variability in pharmaceutical sta-
bility under different conditions. Table 3 clearly shows
that the availability factor for degradation of each SSRI
is higher in aqueous medium compared to solid-phase
medium like the composting system. SSRI degradation
in a solid-phase medium also gave detection of three dif-
ferent metabolites from five different SSRIs after the bio-
logical treatment. Independent of anaerobic or aeration
treatment, SSRIs in aqueous solution gave considerably
higher reduction rates.
Conclusions
Selective serotonin reuptake inhibitors can be effectively
reduced in concentration by aerobic treatment of landfill
leachates. The concentration reduction was close to
complete for all compounds in both concentrations dur-
ing the experimental time of 120 h. Only one of the
known human metabolites (norfluoxetine) was found in
the aeration samples, which suggests other degradation
products than those formed by the human metabolism.
Comparing the results of all SSRIs with different treat-
ment methods, paroxetine and fluvoxamine seem to be
the easiest compounds to eliminate independent of
method, while fluoxetine and sertraline seem to be the
most stable.
Our results suggest that aeration is an effective
method for minimising the impact of pharmaceuticals
such as SSRIs from landfill leachates water. However,
further studies are required to determine what kind of
degradation products are formed, and based on such re-
sults, preventive actions in the form of more sophisti-
cated water treatment systems can be made.
Methods
Aerobic treatment experiment
Leachate from an active landfill (3 L) was diluted with
water (10 L), and the composition of the leachate isgiven in Table 4. Table 4 shows the content of the leach-
ate with carbon source as total organic carbon (TOC),
organic acids and Total-N that will enhance microbial
activity. The strategy of the experiment was to measure
the microbial respiration in the leachate solution spiked
with SSRI tablets and compare it to control flasks with
diluted leachate water without addition of tablets.
Pharmaceutical pollution from landfill leachates will
be as unused tablets or from tablet packages. Therefore,
the stock solution was made up of crushed tablets of each
SSRI that was dissolved in 30 mL methanol (MeOH, Merck,
Darmstadt, Germany) and then diluted with 270 mL dis-
tilled water, stirred and heated for 2 h at 35°C and stored at
4°C until used. Diluted leachate in 500-mL flasks was spiked
with a stock solution of the different SSRIs. The theoretical
starting concentration was 5 and 0.5 mg L−1 for fluvoxamine
and citalopram and 10 and 1 mg L−1 for sertraline, fluoxet-
ine and paroxetine.
The flasks with leachate water were incubated in a
water bath in a Voith Sapromat respirometer (Voith,
Heldenheim/Brenz, Gemany) [30]. The Voith Sapromat
continuously measure consumption of oxygen in solu-
tions and the developed CO2 gas in the flask is trapped
with NaOH (Merck). The experiment was performed in
duplicates, and the samples were incubated for 120 h at
20°C in darkness. The samples were stirred continuously
in closed flasks with a magnet. Total oxygen consump-
tion (Tot. OC) was calculated from the whole tablet
mixture with all excipients, with the background respir-
ation from the leachate after 48 and 120 h, while the
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from the whole tablet mixture with all excipients, with the
background respiration from the leachate (Equation 1)
subtracted. Theoretical oxygen demand (ThOD) for each
SSRI was calculated using the Buswell equation [31]. The
SSRI tablets contain a large number of additives, e.g. car-
bon sources such as cellulose, starch and glycerol. The
tablet mixture used in our experiment contains approxi-
mately 20% SSRIs and 80% excipients.




OC hoursj ¼ Measured oxygen consumption of each
SSRI mg oxygenL−1
 

















tine (γ-[4-(trifluoromethyl)phenoxy]-benzenepropanamine),Table 5 Identification criteria, extraction recoveries, LOD, LOQ
the different SSRIs








Citalopram 9.59 325.5 108.6 35 2
Desmethylcitalopram 9.41 311.1 108.5 28 2
Didesmethylcitalopram 10.14 297.1 108.5 29 2
Citalopram-D6 (IS) - 331.2 108.6 41 2
Paroxetine 10.05 330.2 69.6 40 2
Paroxetine-D4 (IS) - 334.2 73.7 40 2
Fluvoxamine 9.39 319.1 70.6 24 1
Fluoxetine 10.05 310.1 43.8 22 1
Norfluoxetine 9.05 296.1 133.7 15 5
Fluoxetine-D5 (IS) - 315.2 43.8 20 1
Sertraline 9.47 306.1 158.6 18 2
Sertraline-D3 (IS) - 309.1 274.8 17 1
aExtraction recoveries at high/low concentrations. LOD, limit of detection; LOQ, limiand the deuterated standards D3-sertraline, D4-paroxetine,
D5-fluoxetine and D6-citalopram were purchased from To-
ronto Research Chemicals (Toronto, ON, Canada). The
mass spectrometric identification criteria, recoveries, LOD
and LOQ and pKa-values for the compounds are given in
Table 5. pKa values are calculated by Advanced Chemistry
Development (ACD/Labs) Software V8.14 for Solaris, ob-
tained from SciFinder Scholar 2010.
The isotope labelled compounds were used as internal
standards (IS) for quantification. All standards were de-
livered with purity above 98%. Escitalopram, which is
the pure S-enantiomer of citalopram, is not possible to
distinguish from the R-enantiomer with our analytical
techniques, and these enantiomers are measured as the
same compound.
The standards were dissolved in HPLC-grade MeOH
from Merck in concentrations of 100 or 200 μg mL−1,
stored at −18°C in the dark and used as stock solutions.
From this stock solution, the daily work solutions were
made by dilution with purified water.
Solvents for HPLC were HPLC-grade acetonitrile from
Merck, purified water obtained from a MilliQ purifica-
tion unit from Millipore (Bedford, MA, USA) and pro-
analysis-grade formic acid from Merck. The same water
and formic acid were used for liquid-phase microextrac-
tion (LPME), while dihexyl ether (purum ≥ 97%) from
FLUKA (Buchs, Switzerland) was used as organic solvent
to fill the pores of the fibre.
Chemical analysis
The samples were mixed with deionized water (ratio 1:2
by volume) and the pH was measured 30 min after mix-
ing with a Ross electrode (Orion Instruments, Baton





LOD (pg L−1) LOQ (pg L−1) Extraction
recovery (%)
5 3.3 20 60 64/78a
5 3.1 230 760 -
0 2.9 200 780 -
7 3.3 - - -
2 4.1 50 205 140/131a
9 4.1 - - -
7 4.8 130 380 120/122a
5 6.0 150 490 110/84a
5.5 160 540 -
2 6.0 - - -
5 6.4 160 520 100/133a
2 6.4 - - -
t of quantitation.
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ductivity by a Phillips PW 9527 digital meter (Philips,
Eindhoven, Netherlands).
Inorganic parameters of the leachate illustrated in Table 4
were analysed by an accredited laboratory (Eurofins AS)
using Norwegian standards regarding total nitrogen
(Tot-N), TOC, biochemical oxygen demand (BOD7),
total sulphur (Tot-S), SO4 and iron [32]. The leachate
water was also characterized with respect to content of
short-chained organic acids. The organic acids in the
leachate water used in the experiment were alkaline
extracted by adding 0.1 M NaOH (Merck) to the sam-
ples. Concentrated HCl (pro analysis, Merck) was then
added to the water phase and undissociated acids were
then extracted with diethyl ether (>98%, Merck) and
further derivatized by t-butyldimethylsilyl (>99% Sigma
Aldrich, St. Louis, USA) and measured on a gas
chromatograph-mass spectrometer (GC-MS) with elec-
tron impact ionization (EI) after a method described
by Schooley et al. [33].
All samples taken during the experiment were stored
in a freezer at −18°C before chemical extraction and
analysis. Three replicate liquid-phase microextraction
analyses of the SSRIs and metabolites were performed.
An already developed extraction method known as hol-
low fibre-supported liquid-phase microextraction (HF-
LPME or just LPME) was employed to extract the SSRIs
and their metabolites from the samples. The method de-
velopment is described elsewhere [34], and only a brief de-
scription will be given here. Since the SSRI concentration
in the leachate water samples was relatively high, and the
LPME method has proved to be very sensitive for the
SSRIs [8], the samples were diluted to a concentration in
the high end of the calibration curve prior to extraction
(200 ng L−1). The dilution was done with deionized water
to a total volume of 1.1 L. The isotope labelled internal
standards was added in a concentration of 50 ng L−1, and
the pH was adjusted to 12 with 5 M NaOH (Merck) be-
fore the samples were extracted by LPME. Three repli-
cates were analysed from each of the selected days.
A 28-cm-long plasmaphan polypropylene hollow fibre
(Membrana, Wuppertal, Germany) was used for the ex-
traction, and the pores of the fibre were filled with
dihexyl ether by dipping the hollow fibre into the solvent
for 10 s. The excess ether on the fibre surface was re-
moved by dipping it in an ultrasonic bath for 2 to 3 s.
Then the fibre lumen was filled with 20-μL acceptor
phase (purified water/formic acid at pH 2), and the ends
of the fibre were sealed with a thin metal wire. The same
wire was used to keep the fibre hanging in the middle of
the sample bottle. The samples were stirred for 2 h at
800 RPM. After extraction, the extracts were transferred
to Waters (Milford, MA, USA) total recovery HPLC-
vials and analysed using HPLC-MS/MS. The separationwas conducted on a Waters Acquity UPLC BEH C18 col-
umn (1.0 × 150 mm with 1.7-μm particles), and the mo-
bile phases consisted of A: H2O and 0.1% formic acid
and B: 90% acetonitrile, 9.9% H2O and 0.1% formic acid.
The gradient started with a 1-min isocratic elution with
70% A and 30% B; from 1 to 7 min, there was a linear
change in composition to 55% A and 45% B and finally a
linear change from 7 to 12 min to 50% A and 50% B.
The flow rate was set to 50 μL min−1. The mass spectro-
metric detection was done on a triple quadrupole instru-
ment (Waters Quattro Premier XE) in multiple reactions
monitoring mode with positive electrospray ionization
for optimal selectivity and sensitivity. The protonated
molecular ion [M +H] + was used as a precursor ion for
all compounds, and the most intense product ion was
selected for quantification (see Table 2).Calibration curves
Calibration curves were made in the concentration range
1 to 250 ng L−1. The standard samples were set up and
extracted in the same way as the leachate water samples.
Standard samples were extracted and analysed through-
out the experiment period to ensure that the calibration
curves were constant over time. Four internal standards
were used for quantification. Sertraline was quantified
with D3-sertraline as IS; paroxetine with D4-paroxetine;
fluvoxamine, fluoxetine and norfluoxetine with D3-fluox-
etine; and citalopram, desmethylcitalopram and dides-
methylcitalopram with D6-citalopram as IS. The linearity
(R2) of the method ranged between 0.9997 (paroxetine)
and 0.9894 (fluvoxamine) and was considered as good
for all compounds in this concentration range. The lin-
earity of fluvoxamine was a little lower than for the rest
of the compounds, most likely because no isotope la-
belled IS was available for this compound.
The concentration measurements were done on the
basis of the peak area of the analyte divided by the peak
area of the IS, and all concentrations were analysed in
triplicate for each concentration.Quality control
The identification criteria of the SSRIs are given in
Table 5 and consist of correct retention time and the
correct ion transition. Ideally, two or more product ions
should be analysed in the mass spectrometric analysis,
but for four of the five SSRIs, the second product ion is
of too low intensity to be seen at the relevant concentra-
tions; hence, only the most intense ion was used.
The methods limit of detection and limit of quantifica-
tion was found by extracting and analysing a dilution
series of standards in leachate water, and the limits are
given in Table 5. Three parallels of each concentration
were analysed.
Bergersen et al. Environmental Sciences Europe  (2015) 27:6 Page 9 of 9All leachate water samples were extracted and ana-
lysed in triplicate. Between every third sample (nine in-
jections), a blank sample of purified water was analysed to
check for carry-over signals. No carry-over was detected.
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